Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 1, 2015, Pages 101-108

  Li, Ying ^a,b   Guo, Qinglan ^a,b   Wang, Peng ^c   Zhu, Demei ^a,b   Ye, Xinyu ^a,b   Wu, Shi ^a,b   Wang, Minggui ^a,b  

^a FUDAN UNIVERSITY   (China)

^b National Health and Family Planning Commission   (China)

^c SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Acinetobacter baumannii; Clonal dissemination; Extensively drug resistant; Risk factor

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BETA LACTAMASE; BETA LACTAMSE OXA 23; CARBAPENEM; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFEPIME; CEFOPERAZONE; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; MINOCYCLINE; PIPERACILLIN; RIFAMPICIN; SULBACTAM; TIGECYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA-LACTAMASE OXA-23;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHINA; CONSENSUS; GENERAL ANESTHESIA; HOSPITALIZATION; INFECTION CONTROL; INTENSIVE CARE UNIT; MEDICAL RECORD REVIEW; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; TEACHING HOSPITAL; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; BACTERIAL GENE; CASE CONTROL STUDY; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; ENZYMOLOGY; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; PROCEDURES; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CASE-CONTROL STUDIES; CHILD; CHINA; CLUSTER ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY; FEMALE; GENES, BACTERIAL; GENOTYPE; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84921390009     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.04.005     Document Type: Article

References (26)

1. Kempf M., Rolain J.M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents 2012, 39:105-114.
2. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
3. Yamada K., Yanagihara K., Araki N., Harada Y., Morinaga Y., Akamatsu N., et al. Clinical characteristics of tertiary hospital patients from whom Acinetobacter calcoaceticus-Acinetobacter baumannii complex strains were isolated. Intern Med 2012, 51:51-57.
4. Rhomberg P.R., Jones R.N. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). Diagn Microbiol Infect Dis 2009, 65:414-426.
5. Wang F. CHINET 2006 surveillance of bacterial resistance in China. Chin J Infect Chemother 2008, 8:1-9. [Article in Chinese].
6. Wang F., Zhu D., Hu F., Jiang X., Ni Y., Sun J., et al. CHINET 2010 surveillance of bacterial resistance in China. Chin J Infect Chemother 2011, 11:321-329. [Article in Chinese].
7. Chen T.L., Siu L.K., Wu R.C., Shaio M.F., Huang L.Y., Fung C.P., et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect 2007, 13:801-806.
8. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
9. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement M100-S24 2014, CLSI, Wayne, PA.
10. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
11. Versalovic J., Koeuth T., Lupski J.R. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1991, 19:6823-6831.
12. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
13. Fu Y., Zhou J., Zhou H., Yang Q., Wei Z., Yu Y., et al. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J Antimicrob Chemother 2010, 65:644-650.
14. Jeon B.C., Jeong S.H., Bae I.K., Kwon S.B., Lee K., Young D., et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in Korea. J Clin Microbiol 2005, 43:2241-2245.
15. Héritier C., Poirel L., Fournier P.E., Claverie J.M., Raoult D., Nordmann P. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005, 49:4174-4179.
16. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009, 53:5046-5054.
17. Woodford N., Turton J.F., Livermore D.M. Multiresistant gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011, 35:736-755.
18. Mosqueda N., Espinal P., Cosgaya C., Viota S., Plasensia V., Alvarez-Lerma F., et al. Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of Acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain. Antimicrob Agents Chemother 2013, 57:5155-5157.
19. Cristina M.L., Spagnolo A.M., Ottria G., Sartini M., Orlando P., Perdelli F., et al. Spread of multidrug carbapenem-resistant Acinetobacter baumannii in different wards of an Italian hospital. Am J Infect Control 2011, 39:790-794.
20. oxa-23 from hospitals in central Taiwan. J Microbiol Immunol Infect 2013, 46:419-424.
21. Romanelli R.M., Jesus L.A., Clemente W.T., Lima S.S., Rezende E.M., Coutinho R.L., et al. Outbreak of resistant Acinetobacter baumannii-measures and proposal for prevention and control. Braz J Infect Dis 2009, 13:341-347.
22. Sheng W.H., Liao C.H., Lauderdale T.L., Ko W.C., Chen Y.S., Liu J.W., et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis 2010, 14:e764-e769.
23. Chan M.C., Chiu S.K., Hsueh P.R., Wang N.C., Wang C.C., Fang C.T. Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: a case-control study. Plos One 2014, 9:e85973.
24. Olsson G.L., Hallen B., Hambraeus-Jonzon K. Aspiration during anaesthesia: a computer-aided study of 185,358 anaesthetics. Acta Anaesthesiol Scand 1986, 30:84-92.
25. Tsai H.T., Wang J.T., Chen C.J., Chang S.C. Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units. Diagn Microbiol Infect Dis 2008, 62:298-305.
26. Kim S.Y., Jung J.Y., Kang Y.A., Lim J.E., Kim E.Y., Lee S.K., et al. Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit. J Korean Med Sci 2012, 27:939-947.